These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8189051)

  • 1. Peptide-induced conformational changes in class I molecules. Direct detection by flow cytometry.
    Rohren EM; McCormick DJ; Pease LR
    J Immunol; 1994 Jun; 152(11):5337-43. PubMed ID: 8189051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide variants reveal how antibodies recognize major histocompatibility complex class I.
    Hogquist KA; Grandea AG; Bevan MJ
    Eur J Immunol; 1993 Nov; 23(11):3028-36. PubMed ID: 8223880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-induced changes in class I heavy chains alter allorecognition.
    Bluestone JA; Kaliyaperumal A; Jameson S; Miller S; Dick R
    J Immunol; 1993 Oct; 151(8):3943-53. PubMed ID: 8409378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of MHC class I molecules with bound peptide antigens.
    Wilson IA; Fremont DH
    Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-dimensional nuclear magnetic resonance analysis of a labeled peptide bound to a class II major histocompatibility complex molecule.
    Driscoll PC; Altman JD; Boniface JJ; Sakaguchi K; Reay PA; Omichinski JG; Appella E; Davis MM
    J Mol Biol; 1993 Jul; 232(2):342-50. PubMed ID: 8393933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct binding of peptides to MHC class I molecules on living cells. Analysis at the single cell level.
    López JA; Luescher IF; Cerottini JC
    J Immunol; 1992 Dec; 149(12):3827-35. PubMed ID: 1460276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I-peptide interactions and TCR recognition.
    Young AC; Zhang W; Sacchettini JC; Nathenson SG
    Cancer Surv; 1995; 22():17-36. PubMed ID: 7536627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profound enhancement of T cell activation mediated by the interaction between the TCR and the D3 domain of CD4.
    Vignali DA; Vignali KM
    J Immunol; 1999 Feb; 162(3):1431-9. PubMed ID: 9973399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
    Stevanović S; Schild H
    Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.